The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of editing human embryos to make disease-free children.